Lai mei lai de mei pharmacy

Laimei Pharmaceutical mainly develops, produces and sells new drugs, and its products mainly cover two series of anti-infective drugs and special drugs. The main products include quinolones anti-infective drugs, anti-tumor drugs and parenteral nutrition drugs.

At present, the company has more than 400 employees, including more than 250 R&D and technical personnel. Laimei Pharmaceutical has outstanding innovation ability, solid technical foundation, rich industrialization experience and strong marketing network. It is one of the earliest enterprises that passed GMP and GSP certification in China, and the number of new drug applications is among the best in Chongqing.

In order to improve Laimei's existing level and industrial scale, enhance its core competitiveness, further consolidate Laimei's competitive position in the industry, enhance cohesion and attractiveness, and operate more healthily and standardly, Laimei will strive to land in the domestic securities market as soon as possible. Unity and hard work, pragmatic innovation, keep pace with the times.

Have a sense of responsibility, cohesion and transcendence, and work hard for the cause of Laimei. Seeking truth from facts, innovating management, marketing mode and marketing strategy, pioneering and enterprising, grasping the pulse of the times, advancing with the times, and pursuing higher, bigger and stronger sustainable development goals are the spiritual pillars of the Laimei team. Create customer value, create value customers.

Seeking and providing high-quality products, constantly creating more and better social and economic benefits, contributing to the medical development of human society, and building an excellent display platform for employees' value orientation is our unswerving purpose. High quality, high efficiency and dedication to medicine.

Seeking and providing high-quality products, constantly creating more and better social and economic benefits, contributing to the medical development of human society, and building an excellent display platform for employees' value orientation is our unswerving purpose. Service concept-emphasizing morality, honesty, care, professionalism and consideration.

We actively advocate the service of "respecting morality, honesty, caring, professionalism and thoughtfulness".

Pay attention to morality, honesty and trustworthiness-every employee is required to have high quality, good cultivation and noble moral character, pay attention to personality and measure by virtue; Honest and trustworthy. We promise to achieve "three noes" in the publicity and introduction of any products operated by the company, that is, no exaggeration, no falsehood and no concealment. Respect facts, operate in good faith, and behave in good faith. Paying attention to morality is the way for companies to employ people; Honesty is the foundation of the company's career.

Caring for customers and operating with care-We always pay attention to and care for customers, actively provide customers with all-round solutions, focus on the development of the pharmaceutical industry, operate with care, communicate with care and serve with care.

Focus on professional and thoughtful service-we have a professional marketing team, professional service sales, focusing on the cause of Laimei and customer needs; The products operated by the company have strict management and thoughtful service in every link and every time chain from supply, acceptance, warehousing, delivery, sales to after-sales service. 1999 Chongqing laimei pharmaceutical co., ltd was established.

In 2000, large-capacity injection passed GMP certification, and the company's first product "Laimeixing" was produced and listed.

200 1 was recognized as a "high-tech enterprise" in Chongqing by Chongqing Science and Technology Commission.

In 200 1 and 2002, it was rated as "Top Ten Industrial Enterprises in Jiangbei District".

In 2002, small volume injection passed GMP certification.

Since 2002, it has been rated as "Advanced Enterprise of Honesty and Tax Payment in Chongqing" for many times.

In 2004, he moved to Chayuan New Town, Nan 'an District, Chongqing, and passed GMP certification as a whole.

In 2005, Kanalin, the exclusive tumor tracer in the world, was successfully listed.

In 2006, freeze-dried powder injection (anti-tumor, hormone) and powder injection passed GMP certification, and 10 API passed GMP certification respectively.

In 2007, Chongqing Science and Technology Venture Capital Company, one of the top 50 domestic investment institutions, invested in Laimei Pharmaceutical and became a strategic partner of the company.

In 2007, the company was successfully restructured into a joint-stock company-"Chongqing Laimei Pharmaceutical Co., Ltd."

In 2007, it was named "Top Ten Innovative High-tech Enterprises in Chongqing"

In 2007, it was recommended by the Municipal Finance Office as a key listed company in Chongqing.

Tablet PC passed GMP certification in 2008.